Literature DB >> 19222454

Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.

J-H Lee, A-L Cheng, C-W Lin, S-H Kuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19222454     DOI： 10.1111/j.1365-2133.2009.09042.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

Review 1.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

2.  Low-dose Methotrexate Treatment for Solitary or Localized Primary Cutaneous Anaplastic Large Cell Lymphoma: A Long-term Follow-up Study.

Authors:  Jong Bin Park; Myeong Hyeon Yang; Do Ik Kwon; Seol Hwa Seong; Ji Yun Jang; Kee Suck Suh; Min Soo Jang
Journal:  Acta Derm Venereol       Date:  2020-02-29       Impact factor: 3.875

3.  Primary cutaneous anaplastic large cell lymphoma arising from a long-standing erythema nodosum: A case report.

Authors:  Liang-Liang Ma; Shi-Xin Han; Mei-Yun Fang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.